Metal-organic frameworks for drug delivery

Metal−organic frameworks (MOFs) are a class of advanced, structurally diverse materials comprised of inorganic and organic components. The high porosity, large internal surface area, and thermal and chemical stability of these frameworks make them ideal candidates for biomedical applications, in particular for on-demand drug delivery. The design of MOFs for biomedical applications using Zinc Imidazolate Frameworks 8 (ZIF-8) requires a thorough understanding of the effects of this compound on biological tissue. Toxicity assessment of MOFs is initially performed in vitro, with mouse and human cells. Following these in vitro tests, in vivo assessment of MOFs is critical to understand the biodistribution and the pharmacokinetics of these new formulations once administered in the body. 

We performed an extended study of the in vitro toxicity of ZIF-8 on mouse and human cell lines, and assessed the potential use for insulin encapsulation and delivery. Our goal is to develop functional MOFs for diagnostic and therapeutic applications, where we visualize the target area in the body and execute a controlled drug release.

Contacts: Anastasia Terzopoulou, Xiangzhong Chen, Salvador Pané i Vidal

References:


Marcus Hoop, Claudio F. Walde, Raffaele Riccò, Anastasia Terzopoulou, Fajer Mushtaq, Xiang-Zhong Chen, Andrew J. deMello, Paolo Falcaro, Bradley J. Nelson, Josep Puigmartí-Luis, and Salvador Pané, Biocompatibility characteristics of the metal organic framework ZIF-8 for therapeutical applications, Applied Materials Today 11 (2018) 13–21


 

 

 

JavaScript has been disabled in your browser